Showing 2001-2010 of 4878 results for "".
ASDS: Dr. Green on the Annual Meeting
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-green-annual-meeting/29169/Lawrence Green, MD, FAAD, talks about the education and networking that make the American Society for Dermatologic Surgery Annual Meeting special.SCALE 2024: Dr. Linda Stein Gold on What’s New and What’s Coming in AD
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-linda-stein-gold-on-whats-new-and-whats-coming-in-ad/26412/Linda Stein Gold, MD, discusses new topical, oral, and biologic drugs for the treatment of atopic dermatitis at Music City SCALE.What's the last show you binge-watched?
https://practicaldermatology.com/topics/general-topics/whats-the-last-show-you-binge-watched/19875/Nazanin Saedi, MD tells us which show made her laugh and how she can't wait for the next season!Emerging Regenerative Therapies
https://practicaldermatology.com/topics/skin-cancer-photoprotection/emerging-regenerative-therapies/19643/Regenerative medical therapies, particularly PRP, are emerging as safe and efficacious therapies in dermatology. Gary Goldenberg, MD offers an overview.Minimally Invasive Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/minimally-invasive-trends/19055/Michael H. Gold, MD talks about the latest trends in minimally invasive procedures, including for rejuvenation of the neck.DermwireTV Extra: More than Skin Deep
https://practicaldermatology.com/videos/dermwire-tv/more-than-skin-deep/20153/Julie Block, President & CEO at the National Eczema Association, discusses the toll that a child's eczema can take on the whole family. Visit understandad.com to learn more and to access the new Blue’s Clues & You! Storybook.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologiJoin Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciFertility Medications and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/fertility-medications-and-chronic-spontaneous-urticaria/50955/Michelle Tarbox, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the implications of her International Journal of Dermatology article “Fertility Medications and Urticaria Suptypes: Real-World Comparative Study Analyzing Risks Among Clomiphene, GnRH AgonisNew Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.